Ilunocitinib
Ilunocitinib is an orally bioavailable, non-selective JAK inhibitor used in research for canine atopic dermatitis. It is employed in both in vitro and in vivo studies to investigate JAK/STAT pathway inhibition for controlling pruritus and skin inflammation associated with the condition.
Product Specifications
CAS Number
1187594-14-4
Product Name Alternative
Ilunocitinib, LY3411067, LY-3411067
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:200 mg/mL (521.61 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (13.04 mM)
Smiles
N#CCC1 (N2N=CC (=C2) C=3N=CN=C4NC=CC43) CN (C1) S (=O) (=O) C5CC5
Molecular Formula
C17H17N7O2S
Molecular Weight
383.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0021760-01 200 µL
FITC-Linked Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Sign In for Pricing
View Details TRV-0021760-02 1 mL
FITC-Linked Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Sign In for Pricing
View Details 
MBS1179344-01 0.05 mg (E-Coli)
Recombinant Pseudomonas putida UPF0225 protein Pput_1155 (Pput_1155)
Sign In for Pricing
View Details MBS1179344-02 0.05 mg (Yeast)
Recombinant Pseudomonas putida UPF0225 protein Pput_1155 (Pput_1155)
Sign In for Pricing
View Details MBS1179344-03 0.2 mg (E-Coli)
Recombinant Pseudomonas putida UPF0225 protein Pput_1155 (Pput_1155)
Sign In for Pricing
View Details MBS1179344-04 0.5 mg (E-Coli)
Recombinant Pseudomonas putida UPF0225 protein Pput_1155 (Pput_1155)
Sign In for Pricing
View Details